SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-161173
Filing Date
2022-05-26
Accepted
2022-05-26 17:17:06
Documents
14
Period of Report
2022-05-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d322285d8k.htm   iXBRL 8-K 25615
2 EX-99.1 d322285dex991.htm EX-99.1 27915
6 GRAPHIC g322285g0526235451507.jpg GRAPHIC 3587
  Complete submission text file 0001193125-22-161173.txt   189070

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20220526.xsd EX-101.SCH 2528
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20220526_lab.xml EX-101.LAB 18035
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20220526_pre.xml EX-101.PRE 11321
8 EXTRACTED XBRL INSTANCE DOCUMENT d322285d8k_htm.xml XML 3450
Mailing Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4
Business Address SUITE 800 - 114 EAST 4TH AVENUE Vancouver A1 V5T 1G4 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 22971338
SIC: 2834 Pharmaceutical Preparations